At the news
? BEARISHIMPACT 6/10 144 filed Jun 26, 2026 at 16:52 ET
Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. filed paired Form 144 notices on June 26, 2026, signaling intent to sell a combined 467,878 shares of Kymera Therapeutics common stock worth approximately $54.8 million. The filings reveal a coordinated sell-down by a founding venture capital investor alongside an Atlas-affiliated individual (Bruce Booth), with substantial prior sales executed over the preceding week (June 17–25) totaling ~1.1M shares.
- Atlas Venture Fund X, L.P. filed Form 144 to sell 410,427 shares valued at ~$47.8 million.
- Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 57,451 shares valued at ~$6.7 million.
- Combined proposed sale: 467,878 shares worth approximately $54.8 million based on filing price.
- Atlas entities had already sold ~1,058,130 shares in the prior week (June 17–25) for ~$117.2 million, based on transaction detail reported in the filings.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access